Plunkett Research Online: Laboratorios Almirall SA

LABORATORIOS ALMIRALL SA (LBTSF:GREY) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Laboratorios Almirall SA (Almirall) researches, develops, manufactures and markets products for the dermatology market. The company’s products are available in over 70 countries. Current clinical phase projects include: LAS41008, an oral treatment for adult patients with moderate-to-severe plaque .....



Laboratorios Almirall SA
Ticker: LBTSF
Exchange: GREY
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 34 932913000
Fax: 34 932913180
Address: Ronda General Mitre 151
Barcelona, 08022 Spain

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
Pharmaceutical Development
Dermatology
ContactsDescription

Eduardo SanchizCEO
Jorge Gallardo BallartPres.
See More
Laboratorios Almirall SA (Almirall) researches, develops, manufactures and markets products for the dermatology market. The company’s products are available in over 70 countries. Current clinical phase projects include: LAS41008, an oral treatment for adult patients with moderate-to-severe plaque .....See More See More

Auditor:
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
LAS41008
tildrakizumab
P3058
P3073
P3074
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: